trends & perspectives in clinical research

goBalto Chromosome

goBalto Named The 10 Most Recommended Pharma and Biotech Solution Providers 2018

by Craig Morgan

Insights Success recently published its annual Pharma and Life Special Edition announcing the 10 most Recommended Pharma and Biotech Solution Providers of 2018. goBalto was selected for having exhibited integrated and innovative capabilities to handle the unique challenges in the clinical trial space.

Insights Success: The 10 Most Recommended Pharma and Biotech Solution Providers 2018

"Upon review of the 2018 nominees of The 10 Most Recommended Pharma and Biotech Solution Providers 2018, and going through various factors such as preciseness of solution and real-time assistance goBalto stood out with its prompt clinical trials that deliver essential therapies to patients, which has surged the company ahead of its curve," stated the Editor-in-Chief of Insights Success Magazine, Pooja M. Bansal.

Insights Success is a forum where top leaders and executives talk and share about their experiences, views, and mantra for success which will help the young and dynamic bloodline of professionals to learn, cater and deliver business needs for customers in order to become futuristic market leaders.

There have been great strides in technology implementation in the conduct of clinical trials, but product development is still constrained by stubborn bottlenecks often linked to study startup (activities that occur before a study begins). This is widely considered to be the leading cause of long cycle times, which have stagnated for the past 20 years. Too often, if a study is improperly started, it requires rescue, which is a costly practice of adding more sites to complete enrollment targets. This is a big challenge as an estimated 80% of clinical trials fail to meet enrollment timelines. This degree of inefficiency leads to a 94% rise in study timelines.

The continual reliance on spreadsheets, multiple databases and unsecured emails without audit trial is inadequate to manage study startup activities. From a management perspective, the high degree of complexity results in valuable time being wasted—trying to find data buried in documents along with subsequent analyses that are notreadily available. In this environment, a multitude of status meetings to understand the results and key metrics driving startup performance is routine.

goBalto's cloud-based platform accelerates the clinical trial process for pharma and contract research organizations (CROs), offering the industry's only complete end-to-end platform for starting clinical trials, from site identification, feasibility assessment and selection through to activation, with comprehensive metrics to track adherence to timelines and budget. An end-to-end solution with workflows that aggregate data from the disparate sources can identify the documents needed to conform to downstream regulatory requirements and can also signal bottlenecks or breakdowns in study execution. This approach helps avoid rework, delays, and cost overruns; improves cycle times; and facilitates audit readiness.

Read more

Jae Chung
Founder and President
goBalto, Inc
"According to a recent industry survey, organizations are looking at upstream process improvements as an area of significant potential, focusing on study startup processes and leveraging study startup applications as major priorities. Top drivers for moving to purpose-built study startup applications include faster study startup times (63%), improved site feasibility and site selection outcomes (48%), and better visibility into site performance (44%).

Workflow-based technology is critical in the clinical trial continuum, encouraging process optimization, facilitating communications, breaking down organizational silos, and enhancing operational performance and quality."

See how you can accelerate your clinical trials—request a FREE demonstration today.

Recent Posts